neotiv

Alzheimer’s research and patient-centered digital care

Neotiv Logo
About neotiv

Enabling cognitive health

neotiv GmbH develops digital biomarkers for the early detection of neurodegenerative diseases, in particular Alzheimer’s, and integrates them into a user-friendly software platform to support diagnosis and care. The company works closely with academic partners and uses the latest neuroscientific findings.

Management

Dr. Chris Rehse

bmp Ventures Team

Philipp Kopp

Founded

2017

Invested

2021

Stage

Start-up

Industry

Life Sciences & eHealth

Status

Active